Expresión de marcadores hipóxicos y glucolíticos CAIX, GLUT-1, HKII y su relación con la respuesta temprana al tratamiento en carcinoma escamocelular de cuello uterino

Betancourt, 2002, El cáncer. Aspectos básicos sobre su biología, clínica, prevención, diagnóstico y tratamiento. Ministerio de la Protección Social, Instituto Nacional de Cancerología ESE Betancourt, 2007, Anuario estadístico. «Por el control del cáncer», Ministerio de la Protección Social. Instituto Nacional de Cancerología ESE Cendales, 2006, Radioterapia comparada con radioterapia más quimioterapia en el tratamiento del cáncer de cuello uterino en estadio iiiB, Rev Colomb Cancerol, 10, 109 Pouyssegur, 2006, Hypoxia signalling in cancer and approaches to enforce tumour regression, Nature, 441, 437, 10.1038/nature04871 Airley, 2003, GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding, Int J Cancer, 104, 85, 10.1002/ijc.10904 Bachtiary, 2003, Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer, Clin Cancer Res, 9, 2234 Birner, 2000, Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer, Cancer Res, 60, 4693 Gatenby, 2007, Glycolysis in cancer: a potential target for therapy, Int J Biochem Cell Biol, 39, 1358, 10.1016/j.biocel.2007.03.021 Moreno-Acosta P, Gamboa O, Sanchez de Gomez M, Cendales R, Diaz GD, Romero A, et al. IGF1R gene expression as a predictive marker of response to ionizing radiation for patients with locally advanced HPV16-positive cervical cancer. Anticancer Res. 2012;32:4319-25. Xue, 2006, F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy, Gynecol Oncol, 101, 147, 10.1016/j.ygyno.2005.10.005 DeBerardinis, 2008, The biology of cancer: metabolic reprogramming fuels cell growth and proliferation, Cell Metab, 7, 11, 10.1016/j.cmet.2007.10.002 Hatzivassiliou G, Andreadis C, Thompson CB. Akt-directed metabolic alterations in cancer. Drug Discovery Today Disease Mechanisms. 2005;2:255-62. Lee, 2008, Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence, Gynecol Oncol, 108, 377, 10.1016/j.ygyno.2007.10.034 Waggoner, 2003, Cervical cancer, Lancet, 361, 2217, 10.1016/S0140-6736(03)13778-6 IARC Working Group. Human papillomaviruses. IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 64. Lyon: International Agency for Research on Cancer; 1995. Walboomers, 1999, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, 189, 12, 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F Haugland, 2002, Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation, Int J Radiat Oncol Biol Phys, 53, 854, 10.1016/S0360-3016(02)02815-8 Hutchison, 2004, Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix, Clin Cancer Res, 10, 8405, 10.1158/1078-0432.CCR-03-0135 Mayer, 2004, Lack of correlation between expression of HIF-1alpha protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix, Cancer Res, 64, 5876, 10.1158/0008-5472.CAN-03-3566 Parkin, 2005, Global cancer statistics, 2002, CA Cancer J Clin, 55, 74, 10.3322/canjclin.55.2.74 Vaupel, 2004, Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response, Oncologist, 9, 4, 10.1634/theoncologist.9-90005-4 Dayan, 2006, The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha, Cancer Res, 66, 3688, 10.1158/0008-5472.CAN-05-4564 Gatenby, 2008, A microenvironmental model of carcinogenesis, Nat Rev Cancer, 8, 56, 10.1038/nrc2255 Brahimi-Horn, 2006, The role of the hypoxia-inducible factor in tumor metabolism growth and invasion, Bull Cancer, 93, E73 Joost, 2001, The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members [review], Mol Membr Biol, 18, 247, 10.1080/09687680110090456 Mamede, 2005, [18F]FDG uptake and PCNA, Glut-1, and hexokinase-ii expressions in cancers and inflammatory lesions of the lung, Neoplasia, 7, 369, 10.1593/neo.04577 Mendez, 2002, Expression of glucose transporter-1 in cervical cancer and its precursors, Gynecol Oncol, 86, 138, 10.1006/gyno.2002.6745 Pessin, 1992, Mammalian facilitative glucose transporter family: structure and molecular regulation, Annu Rev Physiol, 54, 911, 10.1146/annurev.ph.54.030192.004403 Lal, 2001, Transcriptional response to hypoxia in human tumors, J Natl Cancer Inst, 93, 1337, 10.1093/jnci/93.17.1337 Mayer, 2008, Endogenous hypoxia markers: case not proven!, Adv Exp Med Biol, 614, 127, 10.1007/978-0-387-74911-2_15 Vordermark, 2005, Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells, Int J Radiat Oncol Biol Phys, 61, 1197, 10.1016/j.ijrobp.2004.11.031 Rafajova, 2004, Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase ix expression in cancer cells, Int J Oncol, 24, 995 Pastorek, 1994, Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment, Oncogene, 9, 2877 Yen, 2004, 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression, J Nucl Med, 45, 22 Mayer, 2005, Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers, Clin Cancer Res, 11, 2768, 10.1158/1078-0432.CCR-04-2344 Lyshchik, 2007, Expression of glucose transporter-1, hexokinase-ii, proliferating cell nuclear antigen and survival of patients with pancreatic cancer, Cancer Invest, 25, 154, 10.1080/07357900701208931 Mathupala, 2006, Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria, Oncogene, 25, 4777, 10.1038/sj.onc.1209603 Loncaster, 2001, Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix, Cancer Res, 61, 6394 Tian, 2005, Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging, Ann Nucl Med, 19, 335, 10.1007/BF02984629 Al-Ahmadie, 2008, Carbonic anhydrase ix expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies, Am J Surg Pathol, 32, 377, 10.1097/PAS.0b013e3181570343 Kirkpatrick, 2008, Elevated CAIX expression is associated with an increased risk of distant failure in early-stage cervical cancer, Biomark Insights, 3, 45, 10.4137/BMI.S570 Brown, 2002, Expression of hexokinase ii and Glut-1 in untreated human breast cancer, Nucl Med Biol, 29, 443, 10.1016/S0969-8051(02)00288-3 Hamada, 2009, (18)F-FDG PET analysis of schwannoma: increase of SUVmax in the delayed scan is correlated with elevated VEGF/VPF expression in the tumors, Skeletal Radiol, 38, 261, 10.1007/s00256-008-0612-7 Lamkin, 2009, Glucose as a prognostic factor in ovarian carcinoma, Cancer, 115, 1021, 10.1002/cncr.24126 Robert, 1990, Squamous cell carcinoma of the uterine cerviz –a review with emphasis on prognostic factors and unusual variants, Semin Diagn Pathol, 7, 173 Fan, 2008, Hacking hexokinase halts tumor growth, Cancer Biol Ther, 7, 1136, 10.4161/cbt.7.7.6536 Ivanov, 1998, Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes, Proc Natl Acad Sci USA, 95, 12596, 10.1073/pnas.95.21.12596 Kaluz, 2002, Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase ix in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3’-kinase, Cancer Res, 62, 4469 Liao, 2010, Prognostic relevance of carbonic anhydrase-ix in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study, Gynecol Oncol, 116, 452, 10.1016/j.ygyno.2009.10.062 Ito, 2002, Coexpression of glucose transporter 1 and matrix metalloproteinase-2 in human cancers, J Natl Cancer Inst, 94, 1080, 10.1093/jnci/94.14.1080 Guo-Qing, 2010, A study of association between expression of hOGG1, VDAC1, HK-2 and cervical carcinoma, J Exp Clin Cancer Res, 29, 129, 10.1186/1756-9966-29-129 Hooft L, van der Veldt AA, van Diest PJ, Hoekstra OS, Berkhof J, Teule GJ, et al. [18F]fluorodeoxyglucose uptake in recurrent thyroid cancer is related to hexokinase i expression in the primary tumor. J Clin Endocrinol Metab. 2005;90:328-34. Paudyal, 2008, Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase ii in cases of hepatocellular carcinoma and cholangiocellular carcinoma, Ann Nucl Med, 22, 83, 10.1007/s12149-007-0076-1 Warburg, 1931 Mayer, 2011, GLUT-1 staining of squamous cell carcinomas of the uterine cervix identifies a novel. Element of invasion, Int J Oncol, 38, 145 Amann, 2009, GLUT1 as a therapeutic target in hepatocellular carcinoma, Expert Opin Ther Targets, 13, 1411, 10.1517/14728220903307509 Hedley, 2003, Carbonic anhydrase ix expression, hypoxia, and prognosis in patients with uterine cervical carcinomas, Clin Cancer Res, 9, 5666 Rudlowski, 2003, GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer, Am J Clin Pathol, 120, 691, 10.1309/4KYNQM5862JW2GD7 Mayer, 2005, Carbonic anhydrase ix expression and tumor oxygenation status do not correlate at the microregional level in locally advanced cancers of the uterine cervix, Clin Cancer Res, 11, 7220, 10.1158/1078-0432.CCR-05-0869 Marshall, 1979, Isoenzymes of hexokinase, 6-phosphogluconate dehydrogenase, phosphoglucomutase and lactate dehydrogenase in uterine cancer, Br J Cancer, 40, 380, 10.1038/bjc.1979.192